KPX Lifescience.Co.Ltd

KPX Lifescience.Co.,Ltd. develops, produces, and sells agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally. It supplies raw materials for pharmaceuticals, pesticides, and primary intermediates to the pharmaceutical and agrochemical markets. The company also develops EDP-CL, an intermediate for piperacillin-based antibiotics, including N,N-disuccinimidyl carbonate used for the synthesis of HIV treatment; Amoxapine, an antidepressant raw material; and AM19, an antibiotic intermediate. Formerly known as MNH Laboratories Co., Ltd., it changed its name to KPX Lifescience.Co.,Ltd. in September 2008. Founded in 2005, it is headquartered in Yeosu, South Korea, and is a subsidiary of KPX Holdings Co., Ltd.